» Articles » PMID: 28267783

Fecal Carriage of Extended Spectrum β-lactamase Producing Escherichia Coli and Klebsiella Pneumoniae After Urinary Tract Infection - A Three Year Prospective Cohort Study

Overview
Journal PLoS One
Date 2017 Mar 8
PMID 28267783
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

We have performed a prospective cohort study to investigate the duration of and risk factors for prolonged fecal carriage of ESBL-producing Escherichia coli or Klebsiella pneumoniae in patients with community acquired urinary tract infection caused by these bacteria. From 2009 to 2011, 101 Norwegian patients were recruited. Stool swabs and questionnaires were collected every three months for one year and at the end of the study in 2012. Information on antibiotic prescriptions was collected from the Norwegian Prescription Database. Stool samples were cultured directly on ChromID ESBL agar as well as in an enrichment broth, and culture positive isolates were examined by blaCTX-M multiplex PCR. Isolates without blaCTX-M were investigated for alternative ESBL-determinants with a commercial microarray system. Time to fecal clearance of ESBL producing Enterobacteriaceae was also analysed using Kaplan-Meier estimates. Uni- and multivariate logistic regression was used to compare groups according to previously described risk factors. The ESBL point prevalence of fecal carriage were 61% at 4 months, 56% at 7 months, 48% at 10 months, 39% at 13 months, 19% after two years, and 15% after three years or more. We found no correlation between duration of carriage, comorbidity, antibiotic use or travel to ESBL high-prevalence countries. Prolonged carriage was associated with E. coli isolates of phylogroup B2 or D. Importantly, comparative MLST and MLVA analyses of individual paired urine and fecal E. coli isolates revealed that ESBL production commonly occurred in diverse strains within the same host. When investigating cross-transmission of ESBL producing bacteria in health care institutions, this notion should be taken into account.

Citing Articles

Extended-Spectrum Beta-Lactamase- and Plasmidic AmpC-Producing among the Faecal Samples in the Bulgarian Community.

Stankova P, Boyanova L, Atanasova D, Mihaylova S, Sredkova M, Gergova R Microorganisms. 2024; 12(9).

PMID: 39338452 PMC: 11433957. DOI: 10.3390/microorganisms12091777.


The Roles of a Multidrug-Resistant High-Risk Clone and Its Resistance Plasmids on the Gastrointestinal Colonization and Host-Defense Effectors in the Gut.

Stercz B, Domokos J, Dunai Z, Makra N, Juhasz J, Ostorhazi E Antibiotics (Basel). 2024; 13(8).

PMID: 39199998 PMC: 11350818. DOI: 10.3390/antibiotics13080698.


The Role of the Environment in Dynamics of Antibiotic Resistance in Humans and Animals: A Modelling Study.

Lepper H, Woolhouse M, van Bunnik B Antibiotics (Basel). 2022; 11(10).

PMID: 36290019 PMC: 9598675. DOI: 10.3390/antibiotics11101361.


Duration of rectal colonization with extended-spectrum beta-lactamase-producing Escherichia coli: results of an open, dynamic cohort study in Dutch nursing home residents (2013-2019).

Weterings V, van den Bijllaardt W, Bootsma M, Hendriks Y, Kilsdonk L, Mulders A Antimicrob Resist Infect Control. 2022; 11(1):98.

PMID: 35841002 PMC: 9287922. DOI: 10.1186/s13756-022-01132-9.


Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing between healthcare and community settings: a systematic review and meta-analysis.

Bezabih Y, Bezabih A, Dion M, Batard E, Teka S, Obole A JAC Antimicrob Resist. 2022; 4(3):dlac048.

PMID: 35668909 PMC: 9160884. DOI: 10.1093/jacamr/dlac048.


References
1.
Peirano G, Laupland K, Gregson D, Pitout J . Colonization of returning travelers with CTX-M-producing Escherichia coli. J Travel Med. 2011; 18(5):299-303. DOI: 10.1111/j.1708-8305.2011.00548.x. View

2.
Nielsen K, Dynesen P, Larsen P, Frimodt-Moller N . Faecal Escherichia coli from patients with E. coli urinary tract infection and healthy controls who have never had a urinary tract infection. J Med Microbiol. 2014; 63(Pt 4):582-589. DOI: 10.1099/jmm.0.068783-0. View

3.
Soraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum P . Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country. PLoS One. 2013; 8(7):e69581. PMC: 3720588. DOI: 10.1371/journal.pone.0069581. View

4.
Birkett C, Ludlam H, Woodford N, Brown D, Brown N, Roberts M . Real-time TaqMan PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum beta-lactamases. J Med Microbiol. 2006; 56(Pt 1):52-55. DOI: 10.1099/jmm.0.46909-0. View

5.
Overdevest I, Haverkate M, Veenemans J, Hendriks Y, Verhulst C, Mulders A . Prolonged colonisation with Escherichia coli O25:ST131 versus other extended-spectrum beta-lactamase-producing E. coli in a long-term care facility with high endemic level of rectal colonisation, the Netherlands, 2013 to 2014. Euro Surveill. 2016; 21(42). PMC: 5291152. DOI: 10.2807/1560-7917.ES.2016.21.42.30376. View